Global Consortium Identifies Novel Parkinson's Genetic Risk Factor in African Populations
The discovery of a novel GBA1 variant came from a comprehensive first-of-its-kind genome-wide assessment led by GP2 in 1,488 people with PD and 196,430 control volunteers of African and African admixed ancestry.
- The discovery of a novel GBA1 variant came from a comprehensive first-of-its-kind genome-wide assessment led by GP2 in 1,488 people with PD and 196,430 control volunteers of African and African admixed ancestry.
- BLAAC PD is a cross-sectional study collecting a blood or saliva sample and clinical data from Black and African Americans.
- ASAP launched GP2 in 2019, building on previous funding efforts from MJFF to expand global genetics study in populations traditionally underrepresented in research.
- Fox Foundation supported the Edmond J. Safra Global Genetics Consortia to generate and share genetics data in varied international populations.